San Francisco, CA, United States of America

Nathaniel A Hathaway

This inventor holds 1 USPTO granted patent and 1 published patent application. Top assignee: Harvard College. Active years: 2015.

USPTO Granted Patents = 1 

Average Co-Inventor Count = 5.0

ph-index = 1

Forward Citations = 1(Granted Patents)


Company Filing History:


Years Active: 2015

Loading Chart...
1 patent (USPTO):Explore Patents

Title: Nathaniel A Hathaway: Innovator in Proteasome Activity Enhancement

Introduction

Nathaniel A Hathaway is a notable inventor based in San Francisco, CA. He has made significant contributions to the field of cellular biology, particularly in enhancing proteasome activity. His innovative work has implications for understanding protein degradation processes in cells.

Latest Patents

Hathaway holds a patent for "Methods and compositions for enhancing proteasome activity." This invention relates to methods and compositions that enhance the activity of the proteasome in cells by modulating the activity of Ubp6 in yeast or Usp14 in humans. The methods aim to reduce the inhibitory activity of Usp14 on the proteasome, thereby enhancing its protein-degradation activity. Additionally, the invention provides methods for screening to identify inhibitors of Ubp6, Usp14, or both.

Career Highlights

Nathaniel A Hathaway is associated with Harvard College, where he has been able to collaborate with other prominent researchers in the field. His work has led to advancements in understanding how proteasome activity can be enhanced, which is crucial for various biological processes.

Collaborations

Some of his notable coworkers include Daniel J Finley and John W Hanna. Their collaborative efforts have contributed to the development of innovative methods in cellular biology.

Conclusion

Nathaniel A Hathaway's contributions to enhancing proteasome activity represent a significant advancement in the field of cellular biology. His innovative methods and compositions have the potential to impact various areas of research and therapeutic development.

Profile summary based on public USPTO records.
Please report any incorrect information to [email protected]
Loading…